Publication Information

{'id': 'https://openalex.org/W2591369160', 'doi': 'https://doi.org/10.1200/jco.2005.23.16_suppl.6586', 'title': 'Potential mechanisms for the anti-myeloma properties of bisphosphonates', 'display_name': 'Potential mechanisms for the anti-myeloma properties of bisphosphonates', 'publication_year': 2005, 'publication_date': '2005-06-01', 'ids': {'openalex': 'https://openalex.org/W2591369160', 'doi': 'https://doi.org/10.1200/jco.2005.23.16_suppl.6586', 'mag': '2591369160'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1200/jco.2005.23.16_suppl.6586', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S15137598', 'display_name': 'Journal of Clinical Oncology', 'issn_l': '0732-183X', 'issn': ['0732-183X', '1527-7755'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5060544610', 'display_name': 'Kelly M. Swanson', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2802216851', 'display_name': 'University of Iowa Hospitals and Clinics', 'ror': 'https://ror.org/04g2swc55', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I126307644', 'https://openalex.org/I2802216851']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'K. M. Swanson', 'raw_affiliation_strings': ['Univ of Iowa Hospitals and Clinics, Iowa City, IA'], 'affiliations': [{'raw_affiliation_string': 'Univ of Iowa Hospitals and Clinics, Iowa City, IA', 'institution_ids': ['https://openalex.org/I2802216851']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5033050924', 'display_name': 'Hongyan Tong', 'orcid': 'https://orcid.org/0000-0001-5603-4160'}, 'institutions': [{'id': 'https://openalex.org/I2802216851', 'display_name': 'University of Iowa Hospitals and Clinics', 'ror': 'https://ror.org/04g2swc55', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I126307644', 'https://openalex.org/I2802216851']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'H. Tong', 'raw_affiliation_strings': ['Univ of Iowa Hospitals and Clinics, Iowa City, IA'], 'affiliations': [{'raw_affiliation_string': 'Univ of Iowa Hospitals and Clinics, Iowa City, IA', 'institution_ids': ['https://openalex.org/I2802216851']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5088029990', 'display_name': 'Andrew J. Wiemer', 'orcid': 'https://orcid.org/0000-0002-3029-1780'}, 'institutions': [{'id': 'https://openalex.org/I2802216851', 'display_name': 'University of Iowa Hospitals and Clinics', 'ror': 'https://ror.org/04g2swc55', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I126307644', 'https://openalex.org/I2802216851']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'A. J. Wiemer', 'raw_affiliation_strings': ['Univ of Iowa Hospitals and Clinics, Iowa City, IA'], 'affiliations': [{'raw_affiliation_string': 'Univ of Iowa Hospitals and Clinics, Iowa City, IA', 'institution_ids': ['https://openalex.org/I2802216851']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5058749280', 'display_name': 'Sudha Murthy', 'orcid': 'https://orcid.org/0000-0001-6406-7659'}, 'institutions': [{'id': 'https://openalex.org/I2802216851', 'display_name': 'University of Iowa Hospitals and Clinics', 'ror': 'https://ror.org/04g2swc55', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I126307644', 'https://openalex.org/I2802216851']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'S. Murthy', 'raw_affiliation_strings': ['Univ of Iowa Hospitals and Clinics, Iowa City, IA'], 'affiliations': [{'raw_affiliation_string': 'Univ of Iowa Hospitals and Clinics, Iowa City, IA', 'institution_ids': ['https://openalex.org/I2802216851']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5112117936', 'display_name': 'Raymond J. Hohl', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2802216851', 'display_name': 'University of Iowa Hospitals and Clinics', 'ror': 'https://ror.org/04g2swc55', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I126307644', 'https://openalex.org/I2802216851']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'R. J. Hohl', 'raw_affiliation_strings': ['Univ of Iowa Hospitals and Clinics, Iowa City, IA'], 'affiliations': [{'raw_affiliation_string': 'Univ of Iowa Hospitals and Clinics, Iowa City, IA', 'institution_ids': ['https://openalex.org/I2802216851']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.303, 'has_fulltext': False, 'cited_by_count': 2, 'citation_normalized_percentile': {'value': 0.405825, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 68, 'max': 71}, 'biblio': {'volume': '23', 'issue': '16_suppl', 'first_page': '6586', 'last_page': '6586'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11221', 'display_name': 'Bone health and treatments', 'score': 0.9659, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11221', 'display_name': 'Bone health and treatments', 'score': 0.9659, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11748', 'display_name': 'Organophosphorus compounds synthesis', 'score': 0.9384, 'subfield': {'id': 'https://openalex.org/subfields/1605', 'display_name': 'Organic Chemistry'}, 'field': {'id': 'https://openalex.org/fields/16', 'display_name': 'Chemistry'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}, {'id': 'https://openalex.org/T13304', 'display_name': 'Synthesis and Reactivity of Sulfur-Containing Compounds', 'score': 0.9148, 'subfield': {'id': 'https://openalex.org/subfields/1605', 'display_name': 'Organic Chemistry'}, 'field': {'id': 'https://openalex.org/fields/16', 'display_name': 'Chemistry'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/farnesyl-pyrophosphate', 'display_name': 'Farnesyl pyrophosphate', 'score': 0.8635963}, {'id': 'https://openalex.org/keywords/geranylgeranyl-pyrophosphate', 'display_name': 'Geranylgeranyl pyrophosphate', 'score': 0.8455929}, {'id': 'https://openalex.org/keywords/geranylgeranylation', 'display_name': 'Geranylgeranylation', 'score': 0.8390083}, {'id': 'https://openalex.org/keywords/mevalonate-pathway', 'display_name': 'Mevalonate pathway', 'score': 0.80517155}, {'id': 'https://openalex.org/keywords/geranylgeraniol', 'display_name': 'Geranylgeraniol', 'score': 0.5621056}, {'id': 'https://openalex.org/keywords/farnesyl-diphosphate-synthase', 'display_name': 'Farnesyl diphosphate synthase', 'score': 0.4946353}, {'id': 'https://openalex.org/keywords/isopentenyl-pyrophosphate', 'display_name': 'Isopentenyl pyrophosphate', 'score': 0.49251398}, {'id': 'https://openalex.org/keywords/rab', 'display_name': 'Rab', 'score': 0.45017454}, {'id': 'https://openalex.org/keywords/mevalonic-acid', 'display_name': 'Mevalonic acid', 'score': 0.43445545}], 'concepts': [{'id': 'https://openalex.org/C57790582', 'wikidata': 'https://www.wikidata.org/wiki/Q901141', 'display_name': 'Prenylation', 'level': 3, 'score': 0.89039886}, {'id': 'https://openalex.org/C2776990775', 'wikidata': 'https://www.wikidata.org/wiki/Q2699676', 'display_name': 'Farnesyl pyrophosphate', 'level': 4, 'score': 0.8635963}, {'id': 'https://openalex.org/C2778827360', 'wikidata': 'https://www.wikidata.org/wiki/Q774795', 'display_name': 'Geranylgeranyl pyrophosphate', 'level': 4, 'score': 0.8455929}, {'id': 'https://openalex.org/C23167141', 'wikidata': 'https://www.wikidata.org/wiki/Q14912965', 'display_name': 'Geranylgeranylation', 'level': 4, 'score': 0.8390083}, {'id': 'https://openalex.org/C2779982574', 'wikidata': 'https://www.wikidata.org/wiki/Q14913010', 'display_name': 'Mevalonate pathway', 'level': 4, 'score': 0.80517155}, {'id': 'https://openalex.org/C2778359262', 'wikidata': 'https://www.wikidata.org/wiki/Q3123708', 'display_name': 'Geranylgeraniol', 'level': 3, 'score': 0.5621056}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.5060007}, {'id': 'https://openalex.org/C2775933503', 'wikidata': 'https://www.wikidata.org/wiki/Q25113781', 'display_name': 'Farnesyl diphosphate synthase', 'level': 4, 'score': 0.4946353}, {'id': 'https://openalex.org/C2777654137', 'wikidata': 'https://www.wikidata.org/wiki/Q417403', 'display_name': 'Isopentenyl pyrophosphate', 'level': 4, 'score': 0.49251398}, {'id': 'https://openalex.org/C2776043855', 'wikidata': 'https://www.wikidata.org/wiki/Q55506489', 'display_name': 'Pyrophosphate', 'level': 3, 'score': 0.46259752}, {'id': 'https://openalex.org/C156728348', 'wikidata': 'https://www.wikidata.org/wiki/Q416778', 'display_name': 'Rab', 'level': 3, 'score': 0.45017454}, {'id': 'https://openalex.org/C181199279', 'wikidata': 'https://www.wikidata.org/wiki/Q8047', 'display_name': 'Enzyme', 'level': 2, 'score': 0.44303817}, {'id': 'https://openalex.org/C2780361610', 'wikidata': 'https://www.wikidata.org/wiki/Q241678', 'display_name': 'Mevalonic acid', 'level': 4, 'score': 0.43445545}, {'id': 'https://openalex.org/C81885089', 'wikidata': 'https://www.wikidata.org/wiki/Q189082', 'display_name': 'Cell culture', 'level': 2, 'score': 0.4320304}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.36045367}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.3601167}, {'id': 'https://openalex.org/C112243037', 'wikidata': 'https://www.wikidata.org/wiki/Q22327117', 'display_name': 'ATP synthase', 'level': 3, 'score': 0.353231}, {'id': 'https://openalex.org/C153911025', 'wikidata': 'https://www.wikidata.org/wiki/Q7202', 'display_name': 'Molecular biology', 'level': 1, 'score': 0.32903498}, {'id': 'https://openalex.org/C553450214', 'wikidata': 'https://www.wikidata.org/wiki/Q851162', 'display_name': 'Biosynthesis', 'level': 3, 'score': 0.2972177}, {'id': 'https://openalex.org/C207332259', 'wikidata': 'https://www.wikidata.org/wiki/Q769143', 'display_name': 'GTPase', 'level': 2, 'score': 0.25586262}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1200/jco.2005.23.16_suppl.6586', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S15137598', 'display_name': 'Journal of Clinical Oncology', 'issn_l': '0732-183X', 'issn': ['0732-183X', '1527-7755'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3157133258', 'https://openalex.org/W2591369160', 'https://openalex.org/W2162998993', 'https://openalex.org/W2088730128', 'https://openalex.org/W2061958421', 'https://openalex.org/W2059465572', 'https://openalex.org/W2058275176', 'https://openalex.org/W2036808792', 'https://openalex.org/W2022104391', 'https://openalex.org/W1973023022'], 'abstract_inverted_index': {'6586': [0], 'Background:': [1], 'For': [2], 'cell': [3, 100, 272], 'membrane': [4], 'association,': [5], 'small': [6], 'GTPases': [7], 'such': [8, 48], 'as': [9, 49], 'Ras,': [10], 'Rap1A,': [11], 'Rab,': [12], 'and': [13, 29, 103, 134, 154, 169, 177, 197, 235, 241], 'Rho': [14], 'must': [15], 'undergo': [16], 'post-translational': [17], 'isoprenylation': [18, 54, 238, 253], 'modification.': [19], 'Isoprenoid': [20], 'intermediates': [21], 'of': [22, 57, 66, 82, 95, 113, 132, 152, 239, 245, 254, 265, 291], 'the': [23, 60, 64, 76, 80, 294], 'mevalonate': [24, 92], 'pathway,': [25, 296], 'farnesyl': [26], 'pyrophosphate': [27, 31], '(FPP)': [28], 'geranylgeranyl': [30], '(GGPP),': [32], 'are': [33], 'substrates': [34], 'for': [35, 107, 167, 301], 'farnesylation': [36], 'or': [37, 115], 'geranylgeranylation': [38], 'modifications,': [39], 'respectively.': [40, 183], 'It': [41], 'is': [42, 260, 299], 'reported': [43, 141], 'that': [44, 62, 78, 285], 'nitrogen-containing': [45], 'bisphosphonates': [46], '(BPs),': [47], 'zoledronic': [50], 'acid': [51], '(ZOL),': [52], 'inhibit': [53], 'through': [55], 'inhibition': [56, 266], 'FPP': [58, 133, 168, 213, 228, 251, 275, 278], 'synthase,': [59, 75], 'enzyme': [61, 77], 'catalyzes': [63, 79], 'synthesis': [65, 81], 'FPP.': [67], 'A': [68], 'more': [69, 89, 262], 'significant': [70, 305], 'target': [71, 264], 'could': [72], 'be': [73, 125], 'GGPP': [74, 128, 135, 170, 207, 222, 258, 302], 'GGPP.': [83], 'This': [84], 'study': [85], 'was': [86], 'designed': [87], 'to': [88, 124, 308], 'precisely': [90], 'identify': [91], 'pathway': [93], 'targets': [94], 'BPs.': [96], 'Methods:': [97], 'Human-derived': [98], 'myeloma': [99, 271], 'lines,': [101], 'RPMI-8226': [102, 163], 'ARH-77': [104, 185], 'were': [105, 136, 156, 171, 189], 'incubated': [106], '24': [108], 'hours': [109], 'with': [110, 205, 220, 282], 'either': [111], '50μM': [112, 116], 'ZOL,': [114, 206], 'LWS-138,': [117], 'a': [118, 126, 261], 'novel': [119], 'non-nitrogen': [120], 'containing': [121], 'BP': [122], 'found': [123], 'selective': [127], 'synthase': [129, 259], 'inhibitor.': [130], 'Levels': [131], 'measured': [137], 'using': [138], 'methods': [139], 'recently': [140], '(Tong,': [142], 'H.': [143], 'et': [144], 'al.': [145], 'Analytical': [146], 'Biochemistry,': [147], '336:51,': [148], '2005).': [149], 'Isoprenylation': [150], 'status': [151], 'Rap1A': [153, 240], 'Rab6': [155], 'analyzed': [157], 'by': [158, 210, 216, 225, 231, 267], 'Western': [159], 'blot.': [160], 'Results:': [161], 'In': [162, 184], 'cells,': [164, 182], 'baseline': [165], 'levels': [166, 208, 214, 223, 229, 279], '0.115+/-': [172], '0.009': [173, 192], 'pmol/': [174], '106': [175, 195, 201], 'cells': [176, 186, 196], '0.270': [178], '+/-': [179, 191], '0.010': [180], 'pmol/106': [181], 'these': [187, 255], 'values': [188], '0.144': [190], 'pmol': [193, 199], 'FPP/': [194], '0.250': [198], 'GGPP/': [200], 'cells.': [202], 'When': [203, 218], 'treated': [204, 219], 'decreased': [209, 224], '54%,': [211], 'while': [212, 227, 297], 'increased': [215, 230], '297%.': [217], 'LWS-138': [221, 236, 298], '95%,': [226], '121%.': [232], 'Both': [233], 'ZOL': [234, 283, 286], 'impaired': [237], 'Rab6.': [242], 'The': [243], 'addition': [244], '10μM': [246, 250], 'GGPP,': [247], 'but': [248], 'not': [249], 'restored': [252], 'proteins.': [256], 'Conclusions:': [257], 'likely': [263], 'BPs': [268], 'in': [269], 'human': [270], 'lines': [273], 'than': [274], 'synthase.': [276, 303], 'Increased': [277], 'after': [280], 'treatment': [281], 'suggest': [284], 'may': [287], 'have': [288], 'multiple': [289], 'sites': [290], 'activity': [292], 'on': [293], 'isoprenoid': [295], 'specific': [300], 'No': [304], 'financial': [306], 'relationships': [307], 'disclose.': [309]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2591369160', 'counts_by_year': [], 'updated_date': '2024-12-10T15:57:29.761906', 'created_date': '2017-03-03'}